TY - JOUR
T1 - Plasma C-terminal agrin fragment and rapid kidney function decline in chronic kidney disease patients
AU - Lorenz, Georg
AU - Hettwer, Stefan
AU - McCallum, Wendy
AU - Angermann, Susanne
AU - Wen, Ming
AU - Schmaderer, Christoph
AU - Heemann, Uwe
AU - Roos, Marcel
AU - Renders, Lutz
AU - Steubl, Dominik
N1 - Publisher Copyright:
Copyright © 2019 the Author(s).
PY - 2019/5/1
Y1 - 2019/5/1
N2 - C-terminal agrin fragment (tCAF) is a promising biomarker for glomerular filtration. Data regarding biomarkers that have the ability to predict rapid progression of chronic kidney disease (CKD) are sparse but necessary in order to identify patients at high risk for rapid progression. This study addresses the value of tCAF as a predictor of rapid kidney function decline in CKD patients. We measured plasma tCAF in a retrospective observational cohort study of 277 prevalent CKD patients stage I-V. Using multivariable Cox proportional hazards regression analysis, we evaluated the association of tCAF with end-stage-renal-disease (ESRD), ≥30%-decline of estimated glomerular filtration rate (eGFR) and the composite endpoint of both, adjusting for eGFR, age, systolic blood pressure, proteinuria and diabetes. The median age was 58 [interquartile range 47, 71] years, 36% were female. Median tCAF level was 822 [594, 1232] pM, eGFR was 32 [19, 48] ml/min/1.73 m2. tCAF was correlated to eGFR and proteinuria (r = -0.76 and r = 0.49, P < .001 resp.). During a follow-up of 57.1 [42.9, 71.9] weeks, 36 (13%) patients developed ESRD and 13 (5%) had an eGFR decline of ≥30% (composite endpoint: 49 (18%)). In multivariable analysis, each 100 pM higher tCAF was independently associated with ESRD (hazard ratio (HR) 1.05 (95%-CI 1.02-1.08)), ≥30% eGFR decline (HR 1.10 (1.03–1.18)) and the composite endpoint (HR 1.07 (1.04–1.1)). Plasma tCAF may identify CKD patients at risk for rapid kidney function decline independent of eGFR and other risk factors for eGFR loss such as proteinuria. Abbreviations: ANOVA = analysis of variance, AUC-ROC = area under the receiver operating characteristic curve, BUN = blood urea nitrogen, CKD = chronic kidney disease, CKD-EPI = Chronic Kidney Disease Epidemiology Initiative, CRP = C-reactive protein, eGFR = estimated glomerular filtration rate, ELISA = enzyme-linked immunosorbent assay, ESRD = end-stage renal disease, HR = hazard ratio, pM = picomolar, SBP = systolic blood pressure, tCAF = total C-terminal agrin fragment, VIF = variance inflation factor.
AB - C-terminal agrin fragment (tCAF) is a promising biomarker for glomerular filtration. Data regarding biomarkers that have the ability to predict rapid progression of chronic kidney disease (CKD) are sparse but necessary in order to identify patients at high risk for rapid progression. This study addresses the value of tCAF as a predictor of rapid kidney function decline in CKD patients. We measured plasma tCAF in a retrospective observational cohort study of 277 prevalent CKD patients stage I-V. Using multivariable Cox proportional hazards regression analysis, we evaluated the association of tCAF with end-stage-renal-disease (ESRD), ≥30%-decline of estimated glomerular filtration rate (eGFR) and the composite endpoint of both, adjusting for eGFR, age, systolic blood pressure, proteinuria and diabetes. The median age was 58 [interquartile range 47, 71] years, 36% were female. Median tCAF level was 822 [594, 1232] pM, eGFR was 32 [19, 48] ml/min/1.73 m2. tCAF was correlated to eGFR and proteinuria (r = -0.76 and r = 0.49, P < .001 resp.). During a follow-up of 57.1 [42.9, 71.9] weeks, 36 (13%) patients developed ESRD and 13 (5%) had an eGFR decline of ≥30% (composite endpoint: 49 (18%)). In multivariable analysis, each 100 pM higher tCAF was independently associated with ESRD (hazard ratio (HR) 1.05 (95%-CI 1.02-1.08)), ≥30% eGFR decline (HR 1.10 (1.03–1.18)) and the composite endpoint (HR 1.07 (1.04–1.1)). Plasma tCAF may identify CKD patients at risk for rapid kidney function decline independent of eGFR and other risk factors for eGFR loss such as proteinuria. Abbreviations: ANOVA = analysis of variance, AUC-ROC = area under the receiver operating characteristic curve, BUN = blood urea nitrogen, CKD = chronic kidney disease, CKD-EPI = Chronic Kidney Disease Epidemiology Initiative, CRP = C-reactive protein, eGFR = estimated glomerular filtration rate, ELISA = enzyme-linked immunosorbent assay, ESRD = end-stage renal disease, HR = hazard ratio, pM = picomolar, SBP = systolic blood pressure, tCAF = total C-terminal agrin fragment, VIF = variance inflation factor.
KW - C-terminal agrin fragment
KW - CKD
KW - ESRD
KW - eGFR
KW - phosphate
KW - proteinuria
UR - http://www.scopus.com/inward/record.url?scp=85066060945&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000015597
DO - 10.1097/MD.0000000000015597
M3 - Article
C2 - 31083248
AN - SCOPUS:85066060945
SN - 0025-7974
VL - 98
JO - Medicine (United States)
JF - Medicine (United States)
IS - 19
M1 - e15597
ER -